GenEditBio Limited

GenEditBio is a clinical-stage gene therapy startup with a strategic goal of developing in vivo genome-editing therapeutic solutions (dubbed “DNA surgery”) that are fundamentally safe, precise, efficacious, and affordable for genetic diseases with unmet needs. The Company is established in 2021 and headquartered in Hong Kong, China.